Effect of interventions on antimicrobial use (proportion of patients receiving antimicrobials). by Jessica Craig (409538)

Subjects:

Funnel plot demonstrating lack of publication bias across all studies that met our review’s inclusion criteria. by Jessica Craig (409538)

Subjects:

Effect of interventions on the proportion of isolates/infections resistant to various antimicrobials. by Jessica Craig (409538)

Subjects:

Final quality assessment scores for all studies that met the inclusion criteria. by Jessica Craig (409538)

Subjects:

Title and publication information for all human health studies that met inclusion criteria. by Jessica Craig (409538)

Subjects:

Title and publication information for all animal health studies that met inclusion criteria. by Jessica Craig (409538)

Subjects:

Effect of interventions on the utilization of clinical diagnostic and laboratory tests/cultures and intravenous to oral conversion rates. by Jessica Craig (409538)

Subjects:

Effect of interventions on appropriateness of antimicrobial therapy or adherence to clinical guidelines (including drug selection, dosage, duration, and timing of administration). by Jessica Craig (409538)

Subjects:

Self-reported genitourinary symptoms and their effects on daily activities. by Remi Yoshikata (11419275)

Subjects:

Data from population B analyzed for this report. by Birgit Deboutte (19452787)

“…The heritability estimates of the LI, estimated using Bayesian statistical methods, were high in both populations (0.83 in population A and 0.82 in population B). Improved screening of parents by combining the VMBDD technique with the VDHE, significantly decreased LI and the prevalence of CHD in their offspring. …”

Data from population A analyzed for this report. by Birgit Deboutte (19452787)

“…The heritability estimates of the LI, estimated using Bayesian statistical methods, were high in both populations (0.83 in population A and 0.82 in population B). Improved screening of parents by combining the VMBDD technique with the VDHE, significantly decreased LI and the prevalence of CHD in their offspring. …”

The evaluation of the CAFs marker on each treatment day. by Yoshiaki Tadokoro (16851585)

Subjects:

The effect of transcutaneous CO₂ treatment. by Yoshiaki Tadokoro (16851585)

Subjects:

Minimal dataset for tumor volume and body weight. by Yoshiaki Tadokoro (16851585)

Subjects:

Minimal dataset for immunohistochemical evaluation, IRS score. by Yoshiaki Tadokoro (16851585)

Subjects:

Minimal dataset for quantitative real-time polymerase chain reaction analysis. by Yoshiaki Tadokoro (16851585)

Subjects:

Tumor volume and body weight of mice in control and CO₂-treated groups. by Yoshiaki Tadokoro (16851585)

Subjects:

Raw data underlying the quantitative results reported in the manuscript. by Lai Jiang (2401513)

Subjects:

Outline of study visits. by Jordan K. Abbott (8934239)

Subjects:

S18 Fig - by Jordan K. Abbott (8934239)

Subjects: